Author:
Pandey Rajesh Kumar,S N Singh,Kumar Bharat,Shahnawaz Kashif
Publisher
Akshantala Enterprises Private Limited
Reference12 articles.
1. 1. Murray H.W. Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob. Agents Chemother. 2001; 45: 2185-2197 [Pub. Med].
2. 2. Guerin P, Olliaro P, Sundar S, et al. Visceral leishmaniasis: Current status of control, diagnosis and treatment and a proposed research and development agenda. Lancet Infect Dis. 2002; 2: 494-501 [Pub. Med.].
3. 3. Arias J. R, Monteiro P. S, Zicker F. The re-emergence of visceral leishmaniasis in Brazil. Emerg. Infect. Dis. 1996; 2: 145-146 [Pub. Med.].
4. 4. Ranjan A, Das VNR, Bimal S, et al. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar. Nat. Med. J. India. 2005; 18: 131-133 [Pub. Med.].
5. 5. Branch RA: Prevention of amphotericin B induced renal impairment, a review on the use of sodium supplementation. Arch. Intern. Med. 1988; 148: 2389-2394.